Section Arrow
Quote
ENOV.NYSE
- Enovis Corp
Quotes are at least 15-min delayed:2025/06/28 11:18 EDT
Last
 31.78
-0.48 (-1.49%)
Day High 
32.66 
Prev. Close
32.26 
1-M High
34 
Volume 
9.31M 
Bid
31.31
Ask
32.1
Day Low
31.21 
Open
32.27 
1-M Low
28.83 
Market Cap 
1.84B 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 31.44 
20-SMA 31.65 
50-SMA 33.07 
52-W High 49.83 
52-W Low 28.83 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
-14.59/4.92
Enterprise Value
3.20B
Balance Sheet
Book Value Per Share
45.83
Cash Flow
Cash Flow Yield
0.08
Income Statement
Total Revenue
2.11B
Operating Revenue Per Share
29.08
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
AMIXAutonomix Medical Inc2.01+0.76+60.80%-- 
NAOVNanoVibronix Inc1.17+0.3009+34.62%-- 
BFLYButterfly Network1.96-0.06-2.97%-- 
BBLGBone Biologics Corp4.58+0.42+10.10%0.08PE
BSXBoston Scientific Corp106.53+1.95+1.86%76.05PE
Quotes are at least 15-min delayed：2025/06/28 11:18 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.